The QualityStocks Daily Thursday, April 5th, 2018

Today's Top 3 Investment Newsletters

Schaeffer's (LFIN) +64.86%

SmallCapVoice (RXMD) +38.26%

MissionIR (NETE) +32.98%

The QualityStocks Daily Stock List

Explor Resources, Inc. (EXSFF)

Streetwise Reports, Vantage Wire, Stockhouse, and InvestorsHub reported earlier on Explor Resources, Inc. (EXSFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Explor Resources, Inc. is a natural resources company headquartered in Rouyn-Noranda, Quebec. The Company has mineral holdings in Ontario, Quebec, Saskatchewan and New Brunswick. Its Flagship project is the Timmins Porcupine West (TPW) Project situated in the Porcupine mining camp in Ontario. A gold and base metals exploration company, Explor Resources lists on the OTC Markets Group’s OTCQB.

The Company is presently concentrating on exploration in the Abitibi Greenstone Belt. This belt is in both provinces of Ontario and Quebec - roughly 33 percent in Ontario and 67 percent in Quebec. Explor’s total land position in the Abitibi Greenstone Belt is about 25,000 hectares. In addition, Explor owns 6,500 hectares of mining claims in New Brunswick.

Abitibi Greenstone Belt properties 100 percent-owned by the Company in Ontario include Carnegie, Kidd Township, Eastford Lake, PG-101, Montrose, Golden Harker, Timmins Porcupine West, and Ogden. Abitibi Greenstone Belt properties 100 percent-owned by Explor Resources in Quebec include East Bay, Nelligan, Destor, and Launay.

Explor Resources has signed a Memorandum of Understanding (MOU) with the Matachewan First Nation of Matachewan, Ontario and the Mattagami First Nation of Gogama, Ontario, concerning the Montrose Property. The MOU will serve as a structure to govern the relationship between Explor Resources and the First Nations in accordance with their intention of further building a relationship characterized by cooperation and mutual respect, in connection with the development of the Montrose Property.

The Montrose property consists of 20 mining claims (217 units) positioned in the Montrose and Midlothian Townships in the Timmins-Porcupine Mining Camp for a total of around 3,472 hectares.

In December 2017, Explor Resources announced the acquisition of two mining claims (3 units) located in Ogden Township, in the Porcupine Mining Division, District of Cochrane, Ontario for a total of 48.56 hectares. The claims are in Ogden Township contiguous and to the east of the Timmins Porcupine West Gold Property.

The claims were acquired because of encouraging results obtained in the Company's past exploration on the property. Explor Resources will pay CDN $2,000 and issue 100,000 common shares to obtain a 100 percent interest in the additional Ogden mining claims. The Optionors have retained a 2 percent NSR (Net Smelter Return) in the property.

Last month, Explor Resources announced the results of the East Bay Gold Property exploration program. The analysis of earlier exploration by Cambior and the results of the previous exploration program completed by Explor Resources confirmed a number of interesting drill targets. The exploration program comprised a Phase III 3000 meter drill program.

The East Bay Gold Property is positioned to the west of the Consolidated Beattie and Donchester Gold Property. It is contiguous to the ground on which the former Clifton Star Resources, Inc. intersected wide width of gold mineralization.

Furthermore, Explor Resources announced recently the acquisition of eight mining claims (64 claim units) located in Hoyle Township, in the Porcupine Mining Division, District of Cochrane, Ontario for a total of 1036.4 hectares. The claims are positioned in Hoyle Township, north of Bell Creek, Owl Creek and Hoyle Pond gold Mines.

The claims were obtained because of results attained by Tahoe Resources and Goldcorp in their exploration programs in Hoyle Township. Explor Resources will pay CDN $1,000 and issue 3,000,000 common shares to obtain a 100 percent interest in the property.

Explor Resources, Inc. (EXSFF), closed Thursday's trading session at $0.037, even for the day. The average volume for the last 60 days is 12,595 and the stock's 52-week low/high is $0.022/$0.08.

chart

3PEA International, Inc. (TPNL)

The Next Hot Stock, FeedBlitz, HyperSpeedStocks, Volcano Stocks, OtcWizard, and Nebula Stocks reported on 3PEA International, Inc. (TPNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

3PEA International, Inc. is a vertically integrated provider of unique prepaid card programs and processing services. These are for corporate, consumer, and government applications. By way of its PaySign® brand, the Company designs and develops payment solutions, prepaid card programs, as well as customized payment services. 3PEA International has its corporate office in Henderson, Nevada.

Via the PaySign platform, 3PEA International provides an assortment of services. This includes transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service.

3PEA’s customers include healthcare companies, major pharmaceutical companies, and source plasma providers. In addition, its customers include large multinationals, prestigious universities, and social media companies.

In essence, 3PEA International is a payment processor and debit card program manager. The Company manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention, and adherence. Its customizable prepaid solutions provide major cost savings. This is while improving brand recognition and customer loyalty.

3PEA International has launched the PaySign® brand of prepaid cards. This includes solutions for corporate incentives, payroll, public sector, pharmaceutical co-pay assistance, source plasma donations, general spend reloadable, and other market niches.

The Company has an increased presence in the plasma donation payments space through signing The Interstate Companies and B Positive National Blood Services. 3PEA also entered into an agreement with Visa, whereby 3PEA exclusively issues Visa-branded prepaid cards for the PaySign® brand.

3PEA has expanded its PaySign® brand of prepaid cards to the automotive market with PaySign Connect for Automobile Dealerships. The wide-ranging PaySign Connect prepaid solution is a customizable, multi-purpose platform tailored to the unique needs of auto dealerships.

For Q3 2017, 3PEA International revenue grew 42 percent to $4.0 million versus $2.8 million in the same prior year quarter. Revenue for the nine months ended September 30, 2017 grew 44 percent to $10.6 million from $7.3 million for the same period the year prior.

Gross profit for Q3 2017 increased to $1.86 million versus $1.30 million in the same prior year quarter. Gross profit for the nine months ended September 30, 2017 rose to $4.78 million from $3.30 million for the same period the year prior.

Q3 Net income was $500,168, or $.01 per share. This is in comparison to net income of $480,429 or $.01 per share in the same prior year quarter. Net income for the nine months ended September 30, 2017 was $1,254,004 or $0.03 per share. This is in comparison to $898,040 or $0.02 per share in the same prior year period.

Earlier this month, 3PEA International announced the addition of Bio/Pharma copay offset and reimbursement industry veteran, Mr. Al Negron, to its Executive Team as Senior Vice President Business Development in charge of 3PEA International’s Healthcare vertical.

Mr. Negron is a veteran of the Bio/Pharmaceutical services industry. He has a record of greater than 25 years of success and achievement in speeding up revenue growth, increasing profitability, and expanding market footprints for his Bio/Pharmaceutical clients.

3PEA International, Inc. (TPNL), closed Thursday's trading session at $1.39, up 7.75%, on 153,757 volume with 98 trades. The average volume for the last 60 days is 29,371 and the stock's 52-week low/high is $0.385/$1.29.

chart

Synergy CHC Corp. (SNYR)

SmallCapVoice, OTC Markets, MarketWatch, and TradingView reported earlier on Synergy CHC Corp. (SNYR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Synergy CHC Corp. is a consumer health care company listed on the OTC Markets Group’s OTCQB. It is in the process of building a portfolio of best-in-class consumer product brands. Its business strategy is to increase its portfolio organically and through further acquisition. Established in 2012, Synergy CHC has its corporate office in Westbrook, Maine.

Synergy CHC sells its products primarily in North American retail locations. The Company’s varied portfolio includes FOCUSFactor™, Flat Tummy Tea™, Per-fékt Beauty™, Sneaky Vaunt™, The Queen Pegasus™, Neuragen™, and Hand MD™.

Neuragen® is a topical product. It works directly at the site of the pain contrasted with oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves.

Hand MD® is the world's first anti-aging skincare line formulated specifically for the hands. In addition, Synergy CHC has launched its newest brand, Sneaky Vaunt®.

Flat Tummy Tea™ is an innovatively formulated two-step herbal detox tea. It works to naturally help speed up metabolism, boost energy, and reduce bloating to flatten one’s stomach/tummy.

FOCUSFactor is a nutritional supplement. It includes a proprietary blend of brain supporting vitamins, minerals, antioxidants, and other nutrients.

Synergy CHC officially launched The Synergy Effect, the Company’s ROI (Return on Investment) innovation engine and online marketing platform. The Synergy Effect was built to propel online revenue growth for all of the Company’s brands. The Synergy Effect is a proprietary ROI based algorithm. It uses social media platforms to boost online marketing campaigns and direct to consumer sales.

In 2017, Synergy CHC entered into, and at the same time closed on, an Asset Purchase Agreement with Per-fekt Beauty Holdings, LLC and CDG Holdings, LLC, which owns 92.3 percent of the issued and outstanding equity interests of Per-fekt Beauty. Per-fekt Beauty engages in developing and selling skincare and cosmetics products under the brand Per-fekt.

With the Purchase Agreement, Synergy CHC purchased all of Per-fekt Beauty's assets and assumed certain of its liabilities for a purchase price of $709,988.34.

This week, Synergy CHC reported results for the Fiscal Year (FY) ended December 31, 2017. Net Sales for the FY ended December 31, 2017 were $35.6 million, versus $34.8 million for FY 2016. This represents a 2 percent increase. For FY 2017, Net Income was $0.5 million or $0.01 (basic and diluted) earnings per share, versus a Net Loss of $0.8 million or $0.01 (basic and diluted) loss per share for 2016.

Synergy CHC will be presenting at 2018’s MicroCap Conference on April 9th in New York, New York at 3:00 pm ET. Mr. Jeffrey Kadanoff, Chief Financial Officer of Synergy CHC will be delivering a corporate presentation providing an overview of the Company’s portfolio of brands along with the Synergy Effect.

Synergy CHC Corp. (SNYR), closed Thursday's trading session at $0.32, even for the day. The average volume for the last 60 days is 8,781 and the stock's 52-week low/high is $0.281/$0.80.

chart

Omnitek Engineering Corp. (OMTK)

OTCPicks, Marketbeat, FeedBlitz, and Penny Stock Rumble reported earlier on Omnitek Engineering Corp. (OMTK), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines , which utilize the Company’s technology. These provide its international customers with unique alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering has its head office in Vista, California.

The Company’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. Omnitek Engineering’s dedication is to be at the vanguard of technology. In addition, the Company’s dedication is to develop inventive solutions that redefine the future of low emissions, energy independence, as well as transportation.

Omnitek has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, first for the widely-used Mercedes OM904 and OM906 engines. LKQ is a top provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established the Company as a leader in the industry.

Omnitek has received international certification for its patented fuel rail technology. This is based on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories of Fullerton, California. The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek Engineering will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through utilizing its patented diesel-to-natural gas engine conversion technology. Olson-Ecologic Engine Testing Laboratories will serve as project manager.

Last week, Omnitek Engineering reported results for its Q4 and year ended December 31, 2017. Revenues for Q4 ended December 31, 2017 were $260,004 versus $361,152 a year prior, chiefly because of the timing of foreign sales from development phases to large scale production in foreign markets. For the same period, Omnitek reported a Net Loss of $485,818, or $0.02 per share, versus $193,800, or $0.01 per share, a year prior, mainly because of a non-cash inventory reserve adjustment of $305,458.

Mr. Werner Funk, Omnitek Engineering’s President and Chief Executive Officer, said, “…At this point, air pollution regulations and the price disparity between diesel and natural gas in foreign markets, mostly as a result of higher taxes on diesel fuel, are providing meaningful development programs for Omnitek outside the United States, particularly in Europe and Asia, and we expect a transformative year for the company as sales begin ramping up in these markets.”

Omnitek Engineering Corp. (OMTK), closed Thursday's trading session at $0.0685, up 3.16%, on 4,000 volume with 1 trade. The average volume for the last 60 days is 7,019 and the stock's 52-week low/high is $0.054/$0.194.

chart

Two Rivers Water & Farming Company (TURV)

Jet-Life Penny Stocks, SmallCapVoice, TopPennyStockMovers, IRGnews Alert, Stock News Now, Cannabis Financial Network News, and Stock Guru reported previously on Two Rivers Water & Farming Company (TURV), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the south-western United States. The OTCQB-listed Company assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid south-west are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that produce higher revenues and better profit margins.

Two Rivers Water & Farming has its corporate office in Denver, Colorado. GrowCo, Inc. is an indirect subsidiary of the Company.

Two Rivers’ majority-owned subsidiary, GrowCo, was established in May of 2014 to construct greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, by way of its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to build state-of-the-art greenhouse facilities for licensed marijuana growers. GrowCo centers on the constructing of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

Two Rivers Water & Farming has created a separate company to concentrate on its existing and future investments in water. The new subsidiary is Water Redevelopment Company - a Delaware corporation.

Two Rivers’ initial area of focus is in the Huerfano-Cucharas river basin in south-eastern Colorado. Its current farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado.

The Company provides greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Also, Two Rivers develops Metropolitan Districts to serve underserved communities in rural areas in which Two Rivers' farmland and water rights are situated.

Two Rivers’ produce sells to national accounts through its wholly-owned subsidiary Dionisio Farms & Produce. Regarding Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, acquired in connection with its purchases of irrigated farmland.

Recently, Two Rivers Water & Farming Company announced it is making major progress on its hemp crop share arrangement and water redevelopment project.  The Company stated that land development sales are progressing ahead of plan. Two Rivers' hemp crop share arrangement is with a southern Colorado hemp grower.

At present, the Company values its water and associated land assets at the prior appraised value of roughly $31 million.  Two Rivers believes that with a projected increase in demand for high quality CBD oil and water demand in the next few years, valuation and revenue opportunities of its water assets and hemp activities will also substantially increase. Two Rivers’ core emphasis is its water assets. Therefore, work continues toward the monetization of the Company’s water assets. 

Two Rivers Water & Farming Company (TURV), closed Thursday's trading session at $0.2102, down 7.85%, on 19,998 volume with 15 trades. The average volume for the last 60 days is 107,924 and the stock's 52-week low/high is $0.152/$0.88.

chart

Versus Systems, Inc. (VRSSF)

TradingView, Barchart, and InvestorsHub reported previously on Versus Systems, Inc. (VRSSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Versus Systems, Inc. has developed a proprietary in-game conditional prizing and promotions engine. This engine enables players to compete for and win real prizes from brands that they care about while playing their favorite games. In essence, the Company’s white-label platform gives players the opportunity to play for the things they love, inside of the games they love. Listed on the OTC Markets’ OTCQB, Versus Systems is based in Vancouver, British Columbia.

The Company enables game developers and publishers to provide players with prizes that players can win inside their favorite games. This adds engagement as well as a new dimension to gameplay. Company prizing includes gear, apparel, tickets, energy drinks, and downloadable content from brands such as Tier 1, Han Cholo, Rockstar Energy Drink, and others.

In 2017, Versus Systems announced that it partnered with 704Games to provide in-game prizing in their future titles. 704Games is working with the Company’s prizing and promotions platform to provide players with opportunities for in-game prizing and real-world rewards in their forthcoming titles on mobile and console.

704Games released NASCAR Heat Mobile IN Spring 2017. This is the first authentic NASCAR racing game on mobile to feature 40 stock cars racing at the same time. In addition, 704Games previously announced its NASCAR Heat 2 for Xbox One, Playstation 4, as well as personal computer (PC).

Versus Systems announced this past December a partnership with IDW Media Holdings, Inc. (IDWM) to expand the Versus in-game prize offerings for video gamers. Players will compete, in-game, for access to IDW’s wide-ranging portfolio. IDW Media Holdings publishes comics and graphic novels for Star Trek, Transformers, Teenage Mutant Ninja Turtles, My Little Pony, and more.

At the beginning of March, Versus Systems announced that it entered into a Letter of Engagement with Eight Capital, pursuant to which Eight Capital, acting as agent for Versus Systems, agreed to offer for sale Units of the Company, on a “best efforts” private placement basis, subject to all required regulatory approvals, at a price per Unit of $0.30 for total gross proceeds of up to $3,000,000. The net proceeds from the Offering will be used to enhance marketing efforts and engineering resources.

Versus Systems is developing a blockchain-enabled version of its conditional prizing platform. The Company has been including bitcoin and other cryptocurrencies as potential prizing solutions in all of its Intellectual Property (IP) filings as far back as 2014.

Versus Systems, Inc. (VRSSF), closed Thursday's trading session at $0.2124, down 8.49%, on 1,700 volume with 1 trade. The average volume for the last 60 days is 15,927 and the stock's 52-week low/high is $0.20/$0.6042.

chart

Greystone Logistics, Inc. (GLGI)

Zacks, Trading View, and MarketWatch reported on Greystone Logistics, Inc. (GLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Greystone Logistics, Inc. reprocesses and sells recycled plastic, and designs, manufactures, sells, and leases high-quality 100 percent recycled plastic pallets. These provide logistical solutions needed by a wide array of industries. These industries include food and beverage, agricultural, automotive, chemical, and pharmaceutical and consumer products. A "Green" manufacturing and leasing business, Greystone Logistics is headquartered in Tulsa, Oklahoma.  

The Company is the largest 100 percent recycled plastic pallet manufacturer in the United States. Greystone Logistics provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale. 

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. In addition, its products include picture frame web-top pallets and web-top pallets. Furthermore, the Company sells recycled plastic, which undergoes reprocessing into pellet form. Greystone, also provides pallet leasing services.

Greystone Logistics technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, enables fast production of high-quality pallets and at lower costs than many processes. The recycled plastic for its pallets helps control material costs. This is while lessening environmental waste.

Greystone offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have residual (trade-in) value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have considerably lower life cycle costs (cost per trip), and are suited for closed loop systems. Plastic pallets have no exposed nails, wood chips, or broken boards on manufacturing or warehouse floors. 

This past January, Greystone Logistics reported that Sales for the three months ended November 30, 2017 totaled $9,722,102 versus $9,221,711 for the prior year period. This represents an increase of $511,391, or 6 percent.

Sales for the six months ended November 30, 2017 were $20,009,177 versus $17,065,972 for the prior period. This represents an increase of $2,943,205, or 17 percent.

Greystone Logistics’ Chief Executive Officer, Mr. Warren Kruger, said, “Increased margins while growing sales continue to be a major focus for Greystone. On January 17, 2018, we received a purchase order for our 48X40 heavy duty pallet totaling in excess of $4.5 million from a new national customer..

Greystone Logistics, Inc. (GLGI), closed Thursday's trading session at $0.46, up 5.75%, on 4,500 volume with 2 trades. The average volume for the last 60 days is 23,623 and the stock's 52-week low/high is $0.22/$0.60.

chart

Copper Mountain Mining Corporation (CPPMF)

OTC Markets, InvestorsHub, Barron’s, YCharts, CapitalCube, Morningstar, PennyStockTweets, TradeKing, Stockhouse, 4-Traders, Silicon King, and Barchart reported on Copper Mountain Mining Corporation (CPPMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Copper Mountain Mining Corporation is a mining enterprise listed on the OTC Markets’ OTCQB. The Company’s flagship asset is the Copper Mountain mine located in southern British Columbia, near the town of Princeton. The mine is roughly 20 km south of Princeton and 300 km east of the port of Vancouver. The Copper Mountain mineral claims consist of around 18,000 acres (more than 28 square miles; 73 square km). Copper Mountain Mining has its head office in Vancouver, British Columbia.

The Company has a strategic alliance with Mitsubishi Materials Corporation. Mitsubishi Materials owns 25 percent of the Copper Mountain mine. The Copper Mountain mine produces about 100 million pounds of copper equivalent production per year. This includes major gold and silver credits. All are shipped to Japan for smelting in one of Mitsubishi Materials’ copper smelters.

The Copper Mountain mine (based on the 2015 AIF disclosure) has an expected mine life of 17 years. Resources include 5 Billion lbs of Cu with precious metal credits. Secondary metals include gold, silver - approximately 20 percent of Revenue. This mine is a conventional open pit, truck and shovel operation.

In addition, Copper Mountain Mining has its Fenton project. The Fenton Property is 33 km south of Houston, British Columbia. Fenton is an advanced stage polymetallic exploration project with substantial potential. Copper Mountain Mining has had the property under option since 2012. It has advanced this project through mapping, soil geochemistry, ground and airborne geophysics, and also percussion and diamond drilling.

Recently, Copper Mountain Mining announced all results from its drilling program at the New Ingerbelle deposit at the Copper Mountain mine. The drill program validated and confirmed historical data. As a result, resources that are presently classified as Inferred can now be upgraded to categories based on mineralization continuity and data density.

Moreover, drilling intersected mineralization peripheral to the block model. This indicates the potential for the expansion of resources laterally and at depth. Drill hole assays confirmed the high gold tenor of the Ingerbelle mineralization estimated from historical production data to average 0.66g/t Au for every 1 percent of copper grade.

Altona Mining’s key asset is the 100 percent owned, undeveloped, open pit Cloncurry Copper Project in Queensland, Australia. Currently, Cloncurry has a measured and indicated mineral resource containing more than 2 billion pounds (0.95 million tonnes) of copper and an inferred resource of 1.6 billion pounds (0.72 million tonnes) of copper.

This week, Copper Mountain Mining announced that the Federal Court of Australia made orders approving the scheme of arrangement between Altona Mining Limited and its shareholders. Copper Mountain Mining will acquire all of the shares in Altona. The Company anticipated that Altona would lodge a copy of the Court's orders approving the Scheme with the Australian Securities and Investment Commission (ASIC) on April 4, 2018, at which time the Scheme would become effective.

Copper Mountain Mining Corporation (CPPMF), closed Thursday's trading session at $0.9817, up 10.45%, on 4,620 volume with 5 trades. The average volume for the last 60 days is 50,575 and the stock's 52-week low/high is $0.5367/$1.47.

chart

Novo Integrated Sciences, Inc. (NVOS)

OTC Markets, Stockhouse, MarketWatch, Simply Wall St, InvestorsHub, Corporateinformation, TradingView, Stock Orange, InvestorPlace, and Investing News Alerts reported on Novo Integrated Sciences, Inc. (NVOS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc. is a provider of multi-disciplinary primary healthcare services and products in Canada by way of its wholly-owned Canadian subsidiary Novo Healthnet Limited (NHL). The Company’s mission is to build a U.S. and Canadian based multi-disciplinary primary healthcare service provider, which provides premier specialized healthcare services and products via the integration of technology and medical science.

Novo Integrated Sciences is headquartered in Bellevue, Washington. The Company lists on the OTC Markets Group’s OTCQB. Novo Integrated Sciences was previously known as Turbine Truck Engines, Inc., which was an alternative-energy technology development enterprise.

The Novo Family provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, and massage therapy. It also provides acupuncture, chiropodist, neurological functions, kinesiology, certain dental assessments, certain long-term care services, and other para-medical services to its clients.

Directly and indirectly, by way of its contractual relationships, Novo Healthnet Limited (NHL) provides its specialized services to more than 300,000 patients each year. The Novo Family's services include pain assessment, treatment, management, as well as prevention. These are provided in 14 corporate owned clinics, homes, and institutional locations across Canada.

Furthermore, Novo Healthnet Limited (NHL) recently launched an operational pilot program for its virtual physician access system (telemedicine or virtual medicine.) Its telemedicine system provides patients with real-time access to third-party primary care doctors and specialists in most medical disciplines.

NHL owns a 100 percent stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novo Peak Health, Inc., and an 80 percent stake in Novo Healthnet Kemptville Centre, Inc., all of which are Province of Ontario, Canada companies.

This month, Novo Integrated Sciences announced that it completed the purchase of certain assets of Executive Fitness Leaders (EFL). EFL is an Ottawa, Ontario headquartered local leader in the private personal training sector. EFL provides personal training, massage therapy, nutritional counseling, and corporate wellness services.

Novo Integrated Sciences’ President,  Mr. Chris David, stated, “This transaction is an important milestone in Novo Integrated Sciences’ business strategy that includes growth through strategic acquisitions within the Canadian and U.S. health, wellness and fitness sector, and the subsequent introduction of customized components of our multi-disciplinary primary healthcare services and products that directly complement services and products already provided to the existing customer base of the acquired asset.”

Novo Integrated Sciences, Inc. (NVOS), closed Thursday's trading session at $0.71, up 9.23%, on 6,813 volume with 12 trades. The average volume for the last 60 days is 5,352 and the stock's 52-week low/high is $0.1136/$1.00.

chart

Medizone International, Inc. (MZEI)

Zacks, AwesomePennyStocks, MarketWatch, StockNewsUnion, OTC Markets, Stockhouse, and Amigo Bulls reported on Medizone International, Inc. (MZEI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medizone International, Inc. is centered on commercializing the AsepticSure® System, a premier disinfectant technology. It developed the AsepticSure® System to combine oxidative compounds (O3 and H202) to produce an innovative mixture of free radicals (H2O3 known as trioxidane) with significantly higher oxidative potential than ozone or hydrogen peroxide alone. Medizone International has its corporate office in Kalamazoo, Michigan.

The AsepticSure® hospital disinfection system is a portable, affordable, easily operated system. It can be used by trained maintenance staff.  The AsepticSure® hospital disinfection system is placed in the center of the room to be cleaned.  Vents and doors are subsequently sealed with a removable 3M-tape.

This system is turned on from outside of the room via a remote wireless computer interface. The room is filled with an innovative and patented gas formula. This is ozone-based to specific humidity and charge strength.

After the charge period, the disinfection process is remotely turned off. Moreover a separate technology is utilized, which restores the atmosphere inside the room to EPA (Environmental Protection Agency) standards. The result leaves the treated room devoid of pathogens. In its place is a sweet, fresh oxygen-charged atmosphere.

Recently, Medizone International and Aglon a/s announced that they entered into an agreement for the introduction and distribution of AsepticSure® in the Nordic Region. Medizone granted Aglon a/s exclusive distribution rights for the AsepticSure® system in Norway, Sweden, Denmark, Finland and Iceland.

In addition, Medizone International recently announced the conclusion of an exclusive Product Supply and License Agreement with Innovasource, LLC.
With this Supply Agreement, Innovasource will supply its custom-formulated, EPA-registered hydrogen peroxide based disinfectant product to Medizone International for use in the AsepticSure® Disinfection System.

Furthermore, Innovasource granted to Medizone an exclusive, non-transferable limited license to use Innovasource's intellectual property (IP) in the marketing and sale of the AsepticSure® Disinfection System in the U.S.  The Supply Agreement has a five-year term. It will automatically renew for successive two-year terms. Innovasource is a foremost manufacturer of cleaning, deodorizing, and disinfecting products.

In late November, Medizone International announced that it will meet with representatives of the U.S. Food and Drug Administration (FDA) on January 18, 2018. This meeting is to discuss the planned submission of a marketing application for AsepticSure®.  The FDA has confirmed that the Company’s pre-submission filing contains all required information to permit the FDA to proceed with further review of the submission.

Medizone International, Inc. (MZEI), closed Thursday's trading session at $0.022, up 10.00%, on 145,733 volume with 9 trades. The average volume for the last 60 days is 402,027 and the stock's 52-week low/high is $0.0132/$0.105.

chart

The QualityStocks Company Corner

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in an multi-channel environment including point-of-sale (POS), e-commerce and mobile devices, today announced that its Unified Payments subsidiary has launched “Fast Pass Funding”, a same-day funding service through its proprietary Netevia platform.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Today's trading session at $8.87, up 32.98%, on 1,700 volume with 1 trade. The average volume for the last 60 days is 15,927 and the stock's 52-week low/high is $0.20/$0.6042.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CannabisNewsAudio announces the Audio Press Release (APR) titled "Infusion of Biotechnology into Cannabis Market Leads to Booming Growth," featuring Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX). To hear the NetworkNewsAudio version, visit: http://nnw.fm/jhN9b. To read the original editorial, visit: http://cnw.fm/prTG5.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Today's trading session at $1.01, up 23.17%, on 276,351 volume with 217 trades. The average volume for the last 60 days is 279,074 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

PotNetwork Holding Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holding Inc. (POTN).

PotNetwork Holding (OTC: POTN) this morning announced that it has engaged specialized legal counsel in addition to entering into a specialized engagement with its PCAOB auditors to prepare a Regulation A+ (“Reg A+”) filing. To view the full press release, visit: http://cnw.fm/1Sh1H.

PotNetwork Holding, Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company’s First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holding.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies – Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies – Chill gummies are more robust than its counterpart, the “Relax” gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold – CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD – Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies – Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that’s looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet – CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf – Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD – Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot – CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it’s that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill – CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holding continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holding Inc. plans to expand its subsidiaries as well as make strategic acquisitions.

PotNetwork Holding Inc. (POTN), closed Today's trading session at $0.3971, up 10.31%, on 6,111,818 volume with 1,248 trades. The average volume for the last 60 days is 11,963,835 and the stock's 52-week low/high is $0.0006/$0.957.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Choom™ Holdings Inc. (CSE:CHOO) (CNSX:CHOO) (CHOO.CN) (OTCQB:CHOOF) and its recent progress in securing production capacity and building the foundation for its retail cannabis network.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed Today's trading session at $0.72, up 1.87%, on 90,737 volume with 77 trades. The average volume for the last 60 days is 105,655 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News

chart

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

As the cannabis industry continues to quietly flourish in North America, EVIO, Inc. (OTCQB: EVIO) is providing laboratory testing to help consumers ensure that the plant products they are getting meet stringent standards of healthful quality.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed Today's trading session at $1.25, up 3.31%, on 39,633 volume with 38 trades. The average volume for the last 60 days is 84,250 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotechnology company that operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals and medical devices, is taking active measures to accelerate its development and growth. This new membership is expected to accelerate the development and commercialization of new ETST products in Canada and overseas (http://nnw.fm/2uUtV).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.72, even for the day, on 4,752 volume with 9 trades. The average volume for the last 60 days is 33,110 and the stock's 52-week low/high is $0.324/$1.75.

Recent News

chart

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Amid the frothiness of shifting currents, AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) has built on its pioneering predictive technology to create algorithms that are able to forecast future corporate events with often remarkable precision, and the company markets this tech under a SaaS model that is both affordable and intuitive for retail and institutional clients. Also today, NetworkNewsWire released a report on the company detailing how ATIXF’s proprietary, machine-learning technology is enabling investors to research and invest. To view the full article, visit: http://nnw.fm/GQN5x.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed Wednesday's trading session at $0.314, even for the day. The average volume for the last 60 days is 10,445 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News

chart

IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH).

International remittances are a pivotal pillar for the Philippines economy. The fact is that Filipinos like to send a lot of their money back home. Las Vegas-based IEG Holdings Corporation (OTCQB: IEGH), a publicly traded company which offers unsecured consumer loans in 20 U.S. states, recently announced collaboration with leading blockchain consultants Intellectsoft LLC to explore its ambitions to tap into the growing Philippines remittance market.

IEG Holdings Corp. (OTCQB: IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand “Mr. Amazing Loans.” Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company’s Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company’s loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans’s terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer’s checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH’s other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings’ chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young’s 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting.

IEG Holdings Corp. (IEGH), closed Today's trading session at $0.26, off by 1.89%, on 7,594 volume with 6 trades. The average volume for the last 60 days is 40,654 and the stock's 52-week low/high is $0.14/$4.19.

Recent News

chart

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)

The QualityStocks Daily Newsletter would like to spotlight Victory Square Technologies Inc. (VSQTF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "This Could Be the Year Virtual Reality Conquers the Tech World," featuring Victory Square Technologies, Inc. (CSE: VST) (OTC Pink: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8). To hear the NetworkNewsAudio version, visit http://nnw.fm/ZwhR1. To read the original editorial, visit http://nnw.fm/mI9Md.

Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.

Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.

A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.

Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.

“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”

Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.

“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”

A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.

The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.

In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.

“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.

Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.

Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.

“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”

Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.

Victory Square Technologies Inc. (VSQTF), closed Wednesday's trading session at $1.35, off by 6.25%, on 15,015 volume with 51 trades. The average volume for the last 60 days is 43,341 and the stock's 52-week low/high is $0.298/$3.32.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) believes that its unique cannabinoid-based, nose-to-brain delivery technology, which employs its Sol-gel platform, is on track to become the first of its kind to be FDA-approved. To view the full article, visit: http://cnw.fm/wJ4UK.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed Today's trading session at $0.25, off by 16.11%, on 53,401 volume with 34 trades. The average volume for the last 60 days is 24,832 and the stock's 52-week low/high is $0.01/$0.80.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.